These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23797072)

  • 1. Meningococcal disease in New Zealand.
    Mills G; Bell A
    N Z Med J; 2013 Apr; 126(1373):10-1. PubMed ID: 23797072
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination strategies for the prevention of meningococcal disease.
    Vuocolo S; Balmer P; Gruber WC; Jansen KU; Anderson AS; Perez JL; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1203-1215. PubMed ID: 29543535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Northland emergency meningococcal C vaccination programme.
    Mills C; Penney L
    N Z Med J; 2013 Apr; 126(1373):30-9. PubMed ID: 23797074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is public meningococcal C vaccination the preferred value for money at cost-neutral?
    Gravatt L
    N Z Med J; 2013 Oct; 126(1384):123-5. PubMed ID: 24162638
    [No Abstract]   [Full Text] [Related]  

  • 5. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.
    Ramsay ME; Andrews NJ; Trotter CL; Kaczmarski EB; Miller E
    BMJ; 2003 Feb; 326(7385):365-6. PubMed ID: 12586669
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009.
    Skoczyńska A; Wasko I; Kuch A; Gołebiewska A; Foryś M; Hryniewicz W
    Euro Surveill; 2010 Aug; 15(34):. PubMed ID: 20807486
    [No Abstract]   [Full Text] [Related]  

  • 7. Perils of launching a new vaccination campaign.
    Dobson F
    BMJ; 2014 Apr; 348():g2449. PubMed ID: 24699385
    [No Abstract]   [Full Text] [Related]  

  • 8. Outbreak news. Meningococcal disease, Burkina Faso--update.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):141. PubMed ID: 17465074
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunisation update: Meningococcal B and ACWY vaccines.
    Davidson GT; Heaton PA; Paul SP
    J Fam Health; 2015; 25(6):22-5. PubMed ID: 26749934
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The outbreaks of invasive meningococcal disease in the municipalities of Goleniów and Przybiernów in March 2009. Control measures taken in the outbreak area].
    Gatalska M; Marcinkowska BE; Opiela R; Sygit M
    Przegl Epidemiol; 2011; 65(3):429-32. PubMed ID: 22184943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine shortage threatens spread of meningitis in Niger.
    Maurice J
    Lancet; 2015 Jun; 385(9984):2241. PubMed ID: 26088485
    [No Abstract]   [Full Text] [Related]  

  • 13. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiology and public health: new challenges in surveillance and control of meningococcal disease].
    Abad R; Vázquez JA
    Enferm Infecc Microbiol Clin; 2012 Feb; 30(2):53-5. PubMed ID: 22305483
    [No Abstract]   [Full Text] [Related]  

  • 17. Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
    Pollard AJ; Green C; Sadarangani M; Snape MD
    Arch Dis Child; 2013 Apr; 98(4):248-51. PubMed ID: 23482919
    [No Abstract]   [Full Text] [Related]  

  • 18. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
    Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
    Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective serogroup B meningococcal vaccine.
    Domínguez F; Menéndez J; Ochoa R
    Vaccine; 2006 Nov; 24(49-50):7025-6. PubMed ID: 16879900
    [No Abstract]   [Full Text] [Related]  

  • 20. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.
    Trotter CL; Ramsay ME; Kaczmarski EB
    Commun Dis Public Health; 2002 Sep; 5(3):220-5. PubMed ID: 12434692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.